Cystografin and Yaz drug interactions - a phase IV clinical study of FDA data
Summary:
We study 41,112 people who take Cystografin or Yaz. There is no drug interaction reported.
The phase IV clinical study analyzes what interactions people who take Cystografin and Yaz have. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Cystografin?
Cystografin has active ingredients of diatrizoate meglumine. eHealthMe is studying from 19 Cystografin users for its effectiveness, alternative drugs and more.
What is Yaz?
Yaz has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 41,093 Yaz users for its effectiveness, alternative drugs and more.
Do you take Cystografin and Yaz?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Cystografin (19 reports)
- Yaz (41,093 reports)
How the study uses the data?
The study uses data from the FDA. It is based on diatrizoate meglumine and drospirenone; ethinyl estradiol (the active ingredients of Cystografin and Yaz, respectively), and Cystografin and Yaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cystografin and Yaz.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Renal Cell Carcinoma and Back Disorder - 7 seconds ago
- Raspberry Ketone vs. Vitamin D - 14 seconds ago
- Chronic Fatigue Syndrome in Ramipril, how severe and when it was recovered? - 27 seconds ago
- Diverticulitis and Vulvovaginal Dryness - 32 seconds ago
- Propecia and Arthropathy - 33 seconds ago
- Prozac vs. Norvasc - 44 seconds ago
- Rectal Cancer and Lymphangiosis Carcinomatosa - 57 seconds ago
- Vitamin D and Poor Venous Access - a minute ago
- Ionamin and Hyperuricaemia - a minute ago
- Enbrel and Injection Site Reaction - 2 minutes ago